
Antioxidant BHT 264
CAS:128-37-0
Purity:99%
Contact Now
We will contact you as soon as possible
Your Location:Home >Products >Chemical Reagents >1508250-71-2
Product Details
EGF816, also known as nazartinib, is a covalent, irreversible, third-generation EGFR TKI (epidermal growth factor receptor tyrosine kinase inhibitor). It has activity against EGFR activating and Thr790Met mutations, while sparing wild-type EGFR. It exerts anticancer effects in non-small cell lung cancer.
In this presentation, we report our medicinal chemistry approach and optimization that led to the discovery of EGF816, a selective and potent covalent mutant-selective EGFR inhibitor with single digit nanomolar cellular target modulation on both activating and T790M resistance mutations.